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introduction: Manufacturer/FDA recommend inpatient initiation of dofetilide with the manufacturer providing an initiation algorithm. The 
outcomes of algorithm-adherence has not been evaluated outside clinical trials.
methods: We performed a retrospective review of patients who underwent manufacturer’s algorithm driven initiation on dofetilide at our institute.
results: 189 patients were included in the study with a mean age of 66 (range 34-86) and 68 (36%) females. HTN, CAD and cardiomyopathy 
was seen in 95 (50%), 54 (29%) and 26 (14%) patients respectively. Median QTc was 438 (range 348-530) msec and 116 (61%) were in AF. 
In 16 (8%) patients the drug was discontinued due to intolerance/inefficacy. There were 101 (53%) deviations from the algorithm. Dofetilide 
initiation in patients with a QTc >440msec (>500msec in conduction abnormalities) was the most common deviation occurring in 49 (26%) 
patients. QTc>500msec in non-conduction abnormalities after the first dose was the 2nd most common deviation (34; 18% patients). Ventricular 
tachyarrhythmias occurred in 8 (4%) patients (torsades in 5; ventricular fibrillation in 1 and ventricular tachycardia in 2) and did not differ between 
patients with and without protocol deviations (1.5% vs 2.6%; p = 1.0).
conclusions: Manufacturer recommended algorithm guidelines had frequent deviations and were primarily related to prolonged baseline QTc. 
These protocol deviations were not associated with increase in malignant arrhythmia.
 
